- Home
- GHRS vs FFC Comparison
GHRS vs FFC Comparison
Compare GHRS & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- FFC
- Stock Information
- Founded
- GHRS 2018
- FFC 1983
- Country
- GHRS Ireland
- FFC United States
- Employees
- GHRS N/A
- FFC N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- FFC Trusts Except Educational Religious and Charitable
- Sector
- GHRS Health Care
- FFC Finance
- Exchange
- GHRS Nasdaq
- FFC Nasdaq
- Market Cap
- GHRS 868.7M
- FFC 768.4M
- IPO Year
- GHRS 2021
- FFC N/A
- Fundamental
- Price
- GHRS $12.51
- FFC $16.05
- Analyst Decision
- GHRS Strong Buy
- FFC
- Analyst Count
- GHRS 3
- FFC 0
- Target Price
- GHRS $35.67
- FFC N/A
- AVG Volume (30 Days)
- GHRS 1.1M
- FFC 164.1K
- Earning Date
- GHRS 03-07-2025
- FFC 01-01-0001
- Dividend Yield
- GHRS N/A
- FFC 6.79%
- EPS Growth
- GHRS N/A
- FFC N/A
- EPS
- GHRS N/A
- FFC N/A
- Revenue
- GHRS N/A
- FFC N/A
- Revenue This Year
- GHRS N/A
- FFC N/A
- Revenue Next Year
- GHRS N/A
- FFC N/A
- P/E Ratio
- GHRS N/A
- FFC N/A
- Revenue Growth
- GHRS N/A
- FFC N/A
- 52 Week Low
- GHRS $6.00
- FFC $11.90
- 52 Week High
- GHRS $20.50
- FFC $14.96
- Technical
- Relative Strength Index (RSI)
- GHRS 51.44
- FFC 54.43
- Support Level
- GHRS $13.50
- FFC $15.88
- Resistance Level
- GHRS $14.91
- FFC $16.28
- Average True Range (ATR)
- GHRS 1.58
- FFC 0.14
- MACD
- GHRS -0.22
- FFC 0.01
- Stochastic Oscillator
- GHRS 5.56
- FFC 51.06
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.